Risk of psoriasis among survivors of adult‐onset cancer: a nationwide population‐based cohort study

Abstract

2 Molina GE, Yu Z, Foreman RK et al. Generalized bullous mucocutaneous eruption mimicking Stevens-Johnson syndrome in the setting of immune checkpoint inhibition: a multicenter case series. J Am Acad Dermatol 2020; 83:1475-7. 3 Nguyen ED, Xue YK, Danesh M et al. A case of nivolumab-induced cutaneous toxicity with multiple morphologies. Dermatopathology (Basel) 2020; 6:255-9. 4 Coleman E, Ko C, Dai F et al. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: a single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.

Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study

“… 3 4 5 From the perspective of systemic disease, the pathophysiology mechanism of psoriasis outbreaks can be affected by multiple conditions including smoking, obesity, anemia, and even cancer. 6 7 8 For instance, extrinsic factors including air pollution, drugs, vaccinations, and infections exhibited an association with psoriatic risk, while various intrinsic factors such as diabetes mellitus (DM), dyslipidemia, hypertension (HTN), and mental stress were connected with increased psoriasis risk. 9 Hormone replacement therapy (HRT) has been used widely in menopausal women, exhibiting several benefits such as a decreasing menopause symptoms and the risk of osteoporotic fractures.…”